Dividend-News

Daily dividend news for investors in dividend stocks


Should Gilead Sciences Declare a Dividend?

Published Thu, 17 Jun 2010 10:30:54 -0400 on Seeking Alpha

Investors in Gilead Sciences (GILD) have had quite a run over the past decade. From 1996 through 2008, GILD shares posted gains every single year. During that same 13-year period, the Dow Jones index only posted gains in 8 years. The other 5 years the Dow posted some significant losses. Investors who purchased GILD shares at the beginning of 1996 have experienced a phenomenal 5,922% return. It seemed like the stock could only climb higher each year and the stock split four times from 2001-2006.... Read more

Stock name Last trade   P/E Earnings/Share Dividend/Share Dividend yield
GLAXOSMITHKLINE 41.41   20.9 1.98 1.86 4.52
GILEAD SCIENCES 65.04   14.4 4.53 2.52 3.77
BRISTOL-MYERS SQUIBB 43.33   13.7 3.16 1.64 3.72

GLAXOSMITHKLINE - GSK
GLAXOSMITHKLINE - GSK  


Older articles featuring Glaxosmithkline (GSK):
5%+ Dividend Yield Portfolio: Coping With Existential Dread (May 2019 Review)
5%+ Dividend Yield Portfolio: The Number Of Stocks To Own (Apr 2019 Review)
Sector Study: Healthcare Vs. Technology Dividend Dogs, Which To Buy?
Parking Cash In The Large Cap 5% Dividend Club
Lanny's January Dividend Income Summary
5%+ Dividend Yield Portfolio: Profiting Handsomely From Volatility (Jan 2019 Review)
High Yield Stocks For Investors Looking For Income Options
5%+ Dividend Yield Portfolio: Beating The Market 2 Of The Last 3 Years (December 2018 Review)
5%+ Dividend Yield Portfolio: Profiting From A Return To Normal (October 2018 Review)
Healthcare Yields Of 3% To 4.8% From Top 10 WallStars In November

More